139 related articles for article (PubMed ID: 7531869)
1. Pathogenesis and medical management of benign prostatic hyperplasia.
Appell RA
Semin Nephrol; 1994 Nov; 14(6):531-43. PubMed ID: 7531869
[TBL] [Abstract][Full Text] [Related]
2. Benign prostatic hyperplasia. New concepts in the 1990s.
Moul JW
Postgrad Med; 1993 Nov; 94(6):141-6, 151-2. PubMed ID: 7694269
[TBL] [Abstract][Full Text] [Related]
3. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
Kaplan SA; Olsson CA; Te AE
J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
[TBL] [Abstract][Full Text] [Related]
4. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
[TBL] [Abstract][Full Text] [Related]
5. Benign prostatic hyperplasia: a review.
Ramsey EW
Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
[TBL] [Abstract][Full Text] [Related]
6. [Benign hypertrophy of the prostate: which treatment, for whom?].
Schulman C
Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
[TBL] [Abstract][Full Text] [Related]
7. Managing benign prostatic hyperplasia.
Garnett S; Abrams P
Practitioner; 2001 Oct; 245(1627):830-2, 834, 836 passim. PubMed ID: 11677898
[No Abstract] [Full Text] [Related]
8. Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?
Hall MC; Roehrborn CG; McConnell JD
Semin Urol Oncol; 1996 Aug; 14(3):122-33. PubMed ID: 8865473
[TBL] [Abstract][Full Text] [Related]
9. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.
McConnell JD; Barry MJ; Bruskewitz RC
Clin Pract Guidel Quick Ref Guide Clin; 1994 Feb; (8):1-17. PubMed ID: 7507389
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia.
Jonler M; Riehmann M; Brinkmann R; Bruskewitz RC
Endocrinol Metab Clin North Am; 1994 Dec; 23(4):795-807. PubMed ID: 7535688
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
DiSantostefano RL; Biddle AK; Lavelle JP
BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
[TBL] [Abstract][Full Text] [Related]
12. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians.
Sausville J; Naslund M
Int J Clin Pract; 2010 Dec; 64(13):1740-5. PubMed ID: 21070524
[TBL] [Abstract][Full Text] [Related]
13. [Current drug therapy of benign prostatic hyperplasia].
Schmidbauer CP; Madersbacher S
Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
[TBL] [Abstract][Full Text] [Related]
14. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
[TBL] [Abstract][Full Text] [Related]
15. [Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride].
Teillac P
Therapie; 2002; 57(5):473-83. PubMed ID: 12611202
[TBL] [Abstract][Full Text] [Related]
16. Current treatment of BPH.
Roylance P; Gibelin B; Espié J
Biomed Pharmacother; 1995; 49(7-8):332-8. PubMed ID: 8562858
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological characteristics of familial benign prostatic hyperplasia.
Sanda MG; Doehring CB; Binkowitz B; Beaty TH; Partin AW; Hale E; Stoner E; Walsh PC
J Urol; 1997 Mar; 157(3):876-9. PubMed ID: 9072590
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the patient with benign prostatic hyperplasia.
Carlin BI; Resnick ML
Compr Ther; 1996 Sep; 22(9):586-91. PubMed ID: 8902350
[No Abstract] [Full Text] [Related]
19. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
Keetch DW; Andriole GL; Ratliff TL; Catalona WJ
Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and medical management of benign prostatic hyperplasia.
Beckman TJ; Mynderse LA
Mayo Clin Proc; 2005 Oct; 80(10):1356-62. PubMed ID: 16212149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
